Literature DB >> 24151382

Effects of integrin-targeted photodynamic therapy on pancreatic carcinoma cell.

Min Zhou1, Qian-Wen Ni, Shan-Ying Yang, Chun-Ying Qu, Peng-Cheng Zhao, Jian-Cheng Zhang, Lei-Ming Xu.   

Abstract

AIM: To investigate the effects of photodynamic therapy with quantum dots-arginine-glycine-aspartic acid (RGD) probe as photosensitizer on the proliferation and apoptosis of pancreatic carcinoma cells.
METHODS: Construction of quantum dots-RGD probe as photosensitizer for integrin-targeted photodynamic therapy was accomplished. After cells were treated with photodynamic therapy (PDT), the proliferation of SW1990 cells were measured by methyl thiazolyl tetrazolium assay. Morphologic changes, cell cycle retardance and apoptosis were observed under fluoroscope and flow cytometry. The expression of myeloid cell leukemia-1 (Mcl-1), protein kinase B (Akt) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mRNA were detected by reverse transcription-polymerase chain reaction. The amount of reactive oxygen species were also evaluated by fluorescence probe.
RESULTS: The photodynamic therapy with quantum dots-RGD probe as photosensitizer significantly inhibited cell proliferation (P < 0.01). Apoptotic cells and morphologic changes could be found under optical microscope. The FCM revealed PDT group had more significant cell apoptosis rate compared to control cells (F = 130.617, P < 0.01) and cell cycle G0/G1 and S retardance (P < 0.05) compared to control cells. The expression of Mcl-1 and Akt mRNA were down-regulated, while expression of TRAIL mRNA was up-regulated after cells treated with PDT. PDT group had more significant number of cells producing reactive oxygen species compared to control cells (F = 3262.559, P < 0.01).
CONCLUSION: The photodynamic therapy with quantum dots-RGD probe as photosensitizer significantly inhibits cell proliferation and increases apoptosis in SW1990 cells.

Entities:  

Keywords:  Apoptosis; Pancreatic carcinoma; Photodynamic therapy; Reactive oxygen species; Targeted probe

Mesh:

Substances:

Year:  2013        PMID: 24151382      PMCID: PMC3801369          DOI: 10.3748/wjg.v19.i39.6559

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg-Gly-Asp ligand.

Authors:  Jian-Ping Xiong; Thilo Stehle; Rongguang Zhang; Andrzej Joachimiak; Matthias Frech; Simon L Goodman; M Amin Arnaout
Journal:  Science       Date:  2002-03-07       Impact factor: 47.728

2.  Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

Authors:  Xianzhong Zhang; Zhengming Xiong; Yun Wu; Weibo Cai; Jeffery R Tseng; Sanjiv S Gambhir; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2006-01       Impact factor: 10.057

3.  Tumor-specific expression of the RGD-alpha3(IV)NC1 domain suppresses endothelial tube formation and tumor growth in mice.

Authors:  Toru Miyoshi; Satoshi Hirohata; Hiroko Ogawa; Masayuki Doi; Masanari Obika; Tomoko Yonezawa; Yoshikazu Sado; Shozo Kusachi; Satoru Kyo; Seiji Kondo; Yasushi Shiratori; Billy G Hudson; Yoshifumi Ninomiya
Journal:  FASEB J       Date:  2006-07-28       Impact factor: 5.191

Review 4.  [Quantum dots and their applications in cancer research].

Authors:  Liang-Dong Chen; Yan Li; Hong-Yin Yuan; Dai-Wen Pang
Journal:  Ai Zheng       Date:  2006-05

5.  Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo.

Authors:  C D Liu; D Kwan; R E Saxton; D W McFadden
Journal:  J Surg Res       Date:  2000-09       Impact factor: 2.192

6.  VEGF-integrin interplay controls tumor growth and vascularization.

Authors:  Sarmishtha De; Olga Razorenova; Noel Patrick McCabe; Timothy O'Toole; Jun Qin; Tatiana V Byzova
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

7.  Expression of integrin alphaVbeta3 in pancreatic carcinoma: relation to MMP-2 activation and lymph node metastasis.

Authors:  Ryo Hosotani; Michiya Kawaguchi; Toshihiko Masui; Takatomo Koshiba; Jyun Ida; Koji Fujimoto; Michihiko Wada; Ryuichiro Doi; Masayuki Imamura
Journal:  Pancreas       Date:  2002-08       Impact factor: 3.327

8.  Semiconductor quantum dots for photodynamic therapy.

Authors:  Anna C S Samia; Xiaobo Chen; Clemens Burda
Journal:  J Am Chem Soc       Date:  2003-12-24       Impact factor: 15.419

9.  Beta3-integrin regulates vascular endothelial growth factor-A-dependent permeability.

Authors:  Stephen D Robinson; Louise E Reynolds; Lorenza Wyder; Daniel J Hicklin; Kairbaan M Hodivala-Dilke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

Review 10.  Tumor-targeted photodynamic therapy.

Authors:  Naoto Shirasu; Sung Ouk Nam; Masahide Kuroki
Journal:  Anticancer Res       Date:  2013-07       Impact factor: 2.480

View more
  2 in total

1.  ANGPTL2 expression in gastric cancer tissues and cells and its biological behavior.

Authors:  Wei-Zhong Sheng; Yu-Sheng Chen; Chuan-Tao Tu; Juan He; Bo Zhang; Wei-Dong Gao
Journal:  World J Gastroenterol       Date:  2016-12-21       Impact factor: 5.742

2.  Effects of arginine-glycine-aspartic acid peptide-conjugated quantum dots-induced photodynamic therapy on pancreatic carcinoma in vivo.

Authors:  Ming-Ming Li; Jia Cao; Jia-Chun Yang; Yu-Jie Shen; Xiao-Lei Cai; Yuan-Wen Chen; Chun-Ying Qu; Yi Zhang; Feng Shen; Lei-Ming Xu
Journal:  Int J Nanomedicine       Date:  2017-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.